Hecht M. et al. focused their studies on HGF (hepatocyte growth factor) and its receptor c-Met, and their results showed that TrkB up-regulated HGF and c-Met expression to promote NB cell invasive capability [15]. The gene discussed is NTRK2; the disease is neuroblastoma.